(19)
(11)EP 2 694 017 B1

(12)EUROPEAN PATENT SPECIFICATION

(45)Mention of the grant of the patent:
22.05.2019 Bulletin 2019/21

(21)Application number: 12719132.8

(22)Date of filing:  04.04.2012
(51)International Patent Classification (IPC): 
A61K 8/11(2006.01)
A61K 8/898(2006.01)
A61K 8/73(2006.01)
A61Q 5/12(2006.01)
(86)International application number:
PCT/US2012/032101
(87)International publication number:
WO 2012/138710 (11.10.2012 Gazette  2012/41)

(54)

PERSONAL CLEANSING COMPOSITIONS WITH INCREASED DEPOSITION OF POLYACRYLATE MICROCAPSULES

KÖRPERPFLEGEZUSAMMENSETZUNGEN MIT ERHÖHTER ABSCHEIDUNG VON POLYACRYLAT-MIKROKAPSELN

COMPOSITIONS D'HYGIÈNE PERSONNELLE À DÉPÔT ACCRU DE MICROCAPSULES DE POLYACRYLATE


(84)Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

(30)Priority: 07.04.2011 US 201161472882 P

(43)Date of publication of application:
12.02.2014 Bulletin 2014/07

(73)Proprietor: The Procter & Gamble Company
Cincinnati, OH 45202 (US)

(72)Inventors:
  • DIHORA, Jiten, Odhavji
    Hamilton, Ohio 45011 (US)
  • BROWN, Mark, Anthony
    Union, Kentucky 41091 (US)

(74)Representative: Sauvaître, Thibault Bruno 
Procter & Gamble Service GmbH IP Department Sulzbacher Straße 40-50
65824 Schwalbach am Taunus
65824 Schwalbach am Taunus (DE)


(56)References cited: : 
WO-A1-03/028682
WO-A2-2009/093812
US-A1- 2007 071 978
WO-A2-01/74310
WO-A2-2010/084480
  
     
    Remarks:
    The file contains technical information submitted after the application was filed and not included in this specification
     
    Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).


    Description

    FIELD OF THE INVENTION



    [0001] The present invention relates to personal cleansing compositions containing polyacrylate microcapsules, wherein the polyacrylate microcapsules have increased deposition onto hair and/or skin.

    BACKGROUND OF THE INVENTION



    [0002] Many of the personal cleansing products in the market today work to deliver benefits to hair and/or skin by depositing benefit agents such as perfumes, moisturizers, and skin care agents onto the desired situs. As a result, there is a desire to maximize the effectiveness of such benefit agents by increasing their delivery and retention. One method of achieving this objective is to encapsulate such benefit agents in microcapsules. While these microcapsules are able to encapsulate a wide variety of benefit agents and deliver them to the desired situs, it is still difficult to improve the retention and delivery efficiencies of such benefit agents. Such agents may be lost due to the agents' physical or chemical characteristics, or such agents may be incompatible with other compositional components or the situs that is being treated. Consumers today desire personal cleansing compositions that deposit and retain encapsulated benefit agents onto hair and/or skin, even after an extended period of time.

    [0003] One known method for improving the deposition of microcapsules onto the situs during treatment involves the use of certain cationic deposition polymers. However, this alone does not necessarily ensure adequate deposition of microcapsules.

    [0004] Accordingly, there is a need for a personal cleansing composition that provides an increased deposition of encapsulated benefit agents. In addition, there is a need for a polymer system that associates with microcapsule surfaces, and that when sheared, allows the encapsulated benefit agents to be released. Furthermore, there is a need for a personal cleansing composition that provides an increased retention of encapsulated benefit agents onto the situs for an extended period of time.

    SUMMARY OF THE INVENTION



    [0005] A personal cleansing composition comprising: (a) a premix, the premix comprising from 0.001% to 10%, by weight of the personal cleansing composition, of an anionic charged polyacrylate microcapsule and from 0.01% to 2%, by weight of the personal cleansing composition, of a cationic deposition polymer; (b) from 2% to 50%, by weight of the personal cleansing composition, of a detersive surfactant; and (c) a carrier.

    [0006] A method of making a personal cleansing composition, wherein the composition is formed by a process comprising the steps of: coating a polyacrylate microcapsule with an anionic emulsifier to form an anionic polyacrylate microcapsule; combining the anionic polyacrylate microcapsule with a cationic deposition polymer to form a premix; adding the premix to a detersive composition comprising surfactant and a carrier.

    [0007] A method of making a personal cleansing composition, wherein the composition is formed by a process comprising the steps of: coating a polyacrylate microcapsule with an anionic emulsifier to form an anionic polyacrylate microcapsule; combining the anionic polyacrylate microcapsule with a cationic deposition polymer to form a premix; adding the premix to an anionic surfactant; adding the resulting composition of step (c) to a detersive composition comprising surfactant and a carrier.

    DETAILED DESCRIPTION OF THE INVENTION



    [0008] In all embodiments of the present invention, all percentages are by weight of the total composition, unless specifically stated otherwise. All ratios are weight ratios, unless specifically stated otherwise. All ranges are inclusive and combinable. The number of significant digits conveys neither a limitation on the indicated amounts nor on the accuracy of the measurements. All numerical amounts are understood to be modified by the word "about" unless otherwise specifically indicated. Unless otherwise indicated, all measurements are understood to be made at 25°C and at ambient conditions, where "ambient conditions" means conditions under about one atmosphere of pressure and at about 50% relative humidity. All such weights as they pertain to listed ingredients are based on the active level and do not include carriers or by-products that may be included in commercially available materials, unless otherwise specified.

    Definitions



    [0009] As used herein, the term "personal cleansing composition" includes, unless otherwise indicated, any personal cleansing composition that can be applied to the keratinaceous surfaces of the body including the skin and/or hair. The personal cleansing compositions can be, for example, formulated as cleaning bars, liquids, emulsions, shower gels, powders, sticks, pastes, mouthwashes, foam baths, shave prep products, and devices used for shaving.

    [0010] As used herein, the term "fluid" includes liquids and gels.

    [0011] As used herein, the terms "microcapsule," "encapsulated benefit agents," and "solid particulates," refers to polyacrylate microcapsules.

    [0012] As used herein, the term "premix" refers to the combination of anionic polyacrylate microcapsules with cationic deposition polymers.

    [0013] As used herein, the term "situs" includes hair and skin.

    [0014] As used herein, the articles including "a" and "an" when used in a claim, are understood to mean one or more of what is claimed or described.

    [0015] As used herein, the terms "include," "includes," and "including," are meant to be non-limiting.

    [0016] The test methods disclosed in the Test Methods Section of the present application should be used to determine the respective values of the parameters of Applicants' inventions.

    [0017] Unless otherwise noted, all component or composition levels are in reference to the active portion of that component or composition, and are exclusive of impurities, for example, residual solvents or by-products, which may be present in commercially available sources of such components or compositions.

    [0018] All percentages and ratios are calculated by weight unless otherwise indicated. All percentages and ratios are calculated based on the total composition unless otherwise indicated.

    Benefits of Anionic Polyacrylate Microcapsules



    [0019] Consumers desire personal cleansing compositions that deposit and retain encapsulated benefit agents onto their hair and/or skin during the cleansing process. Traditionally, a variety of approaches have been employed to improve deposition of microcapsules, including (1) using specific block copolymers to covalently bind to the microcapsules, and (2) using cationic water soluble polymers to coat the microcapsules in order to increase the affinity of the microcapsules to the substrate of interest. However, it is desired to have improved deposition over the traditional approaches.

    [0020] It has been surprisingly found that a synergy exists between anionic emulsifiers and polyacrylate microcapsules, resulting in anionic polyacrylate microcapsules. When such anionic microcapsules are mixed with cationic deposition polymers, microstructures are formed at the surface of the anionic polyacrylate. Such anionic microstructures display high viscoelasticity, remain in tact even upon dilution during cleansing, and display strong adhesion to keratinaceous hair and/or skin surfaces. Combined with cleansing compositions, these properties result in improved delivery efficiency of the encapsulated benefit agents to hair and/or skin.

    [0021] It is believed that the personal cleansing compositions comprising anionic polyacrylate microcapsules, along with specific cationic deposition polymers, delivers a higher deposition rate than personal cleansing compositions containing non-anionic polyacrylates. In addition, anionic polyacrylate microcapsules with specific cationic deposition polymers also have a higher retention rate on the situs even over an extended period of time. Applicants surprising discovery of adding anionic emulsifier to microcapsules to form anionic microcapsules can be accomplished by either: (1) adding the anionic emulsifier to an already formed microcapsule or (2) allowing the anionic emulsifier to associate with the microcapsule surface during the microcapsule making process. Once formed, the anionic polyacrylate microcapsules are combined with the specific cationic polymer(s) chosen to form a premix for addition to an anionic surfactant containing personal cleansing composition.

    Anionic Emulsifier



    [0022] The addition of an anionic emulsifier forms a microstructure with a specified cationic deposition polymer at the external surface of the microcapsules, i.e., the anionic emulsifier is at least a part of the external surface of the microcapsules, or is physically or chemically bound to the external surface of the microcapsules. Such physical bindings include, for example, hydrogen bonding, ionic interactions, hydrophobic interactions, and electron transfer interactions. Such chemical bindings include, for example, covalent bindings such as covalent grafting and crosslinking.

    [0023] The anionic emulsifier is present at a level by weight of from about 0.1% to about 40%, from about 0.5% to about 10%, or from about 0.5% to about 5%, by weight of the polyacrylate microcapsule.

    [0024] A variety of anionic emulsifiers can be used in the personal cleansing composition of the present invention as described below. The anionic emulsifiers include, by way of illustrating and not limitation, water-soluble salts of alkyl sulfates, alkyl ether sulfates, alkyl isothionates, alkyl carboxylates, alkyl sulfosuccinates, alkyl succinamates, alkyl sulfate salts such as sodium dodecyl sulfate, alkyl sarcosinates, alkyl derivatives of protein hydrolyzates, acyl aspartates, alkyl or alkyl ether or alkylaryl ether phosphate esters, sodium dodecyl sulphate, phospholipids or lecithin, or soaps, sodium, potassium or ammonium stearate, oleate or palmitate, alkylarylsulfonic acid salts such as sodium dodecylbenzenesulfonate, sodium dialkylsulfosuccinates, dioctyl sulfosuccinate, sodium dilaurylsulfosuccinate, poly(styrene sulfonate) sodium salt, isobutylene-maleic anhydride copolymer, gum arabic, sodium alginate, carboxymethylcellulose, cellulose sulfate and pectin, poly(styrene sulfonate), isobutylene-maleic anhydride copolymer, gum arabic, carrageenan, sodium alginate, pectic acid, tragacanth gum, almond gum and agar; semi-synthetic polymers such as carboxymethyl cellulose, sulfated cellulose, sulfated methylcellulose, carboxymethyl starch, phosphated starch, lignin sulfonic acid; and synthetic polymers such as maleic anhydride copolymers (including hydrolyzates thereof), polyacrylic acid, polymethacrylic acid, acrylic acid butyl acrylate copolymer or crotonic acid homopolymers and copolymers, vinylbenzenesulfonic acid or 2-acrylamido-2-methylpropanesulfonic acid homopolymers and copolymers, and partial amide or partial ester of such polymers and copolymers, carboxymodified polyvinyl alcohol, sulfonic acid-modified polyvinyl alcohol and phosphoric acid-modified polyvinyl alcohol, phosphated or sulfated tristyrylphenol ethoxylates.

    [0025] In addition, it is desirable to use anionic emulsifiers that have acrylate functionality since these can be covalently linked to the shell portion of the polyacrylate microcapsules during the microcapsule making process. Anionic emulsifiers useful herein include, but aren't limited to: poly(meth)acrylic acid; copolymers of (meth)acrylic acids and its (meth)acrylates with C1-22 alkyl, C1-C8 alkyl, butyl; copolymers of (meth)acrylic acids and (meth)acrylamide; Carboxyvinylpolymer; acrylate copolymers such as Acrylate/C10-30 alkyl acrylate crosspolymer, Acrylic acid/vinyl ester copolymer/Acrylates/Vinyl Isodecanoate crosspolymer, Acrylates/Palmeth-25 Acrylate copolymer, Acrylate/Steareth-20 Itaconate copolymer, and Acrylate/Celeth-20 Itaconate copolymer; Polystyrene sulphonate, copolymers of methacrylic acid and acrylamidomethylpropane sulfonic acid, and copolymers of acrylic acid and acrylamidomethylpropane sulfonic acid; carboxymethycellulose; carboxy guar; copolymers of ethylene and maleic acid; and acrylate silicone polymer. Neutralizing agents may be included to neutralize the anionic emulsifiers herein. Non-limiting examples of such neutralizing agents include sodium hydroxide, potassium hydroxide, ammonium hydroxide, monoethanolamine, diethanolamine, triethanolamine, diisopropanolamine, aminomethylpropanol, tromethamine, tetrahydroxypropyl ethylenediamine, and mixtures thereof. Commercially available anionic emulsifiers include, for example, Carbomer supplied from Noveon under the tradename Carbopol 981 and Carbopol 980; Acrylates/C10-30 Alkyl Acrylate Crosspolymer having tradenames Pemulen TR-1, Pemulen TR-2, Carbopol 1342, Carbopol 1382, and Carbopol ETD 2020, all available from Noveon; sodium carboxymethylcellulose supplied from Hercules as CMC series; and Acrylate copolymer having a tradename Capigel supplied from Seppic. In another embodiment, anionic emulsifiers are carboxymethylcelluloses.

    Polyacrylate Microcapsules



    [0026] Various processes for microencapsulation, and exemplary methods and materials, are set forth in U.S. Patent 6,592,990; U.S. Patent 2,730,456; U.S. Patent 2,800,457; U.S. Patent 2,800,458; and U.S. Patent 4,552,811.

    [0027] The present invention teaches a low permeability microcapsule comprising a core material and a wall material at least partially surrounding, and in one embodiment, completely surrounding, a core material. In the present invention, the polyacrylate microcapsules are benefit agent microcapsule particulates which encapsulate benefit agents by capsule wall materials comprised of polymers.

    [0028] Capsule wall materials useful herein include, for example, those formed from melamine-formaldehyde or urea-formaldehyde condensates, melamine-resorcinol or urea-resorcinol condensates, as well as similar types of aminoplasts, gelatin, polyurethane, polyamide, polyolefin, polysaccaharide, protein, silicone, lipid, modified cellulose, gums, polyacrylate, polyphosphate, polystyrene, and polyesters, or combinations of these materials. In another embodiment, a wall material that provides low permeability is polyacrylate.

    [0029] The benefit agents of the core may comprise a material selected from the group consisting of perfumes; brighteners; enzymes; perfumes; skin care agents, conditioning agents, moisturizers, thickeners; anti-microbial agents; sensates in one aspect a cooling agent; attractants, in one aspect a pheromone; anti-bacterial agents; dyes; pigments; bleaches; and mixtures thereof.

    [0030] The present invention may further comprise one or more anti-fungal or anti-microbial actives. When present, the antimicrobial bar composition can include from about 0.001% to about 5%, in another embodiment from about 0.01% to about 1.5%, and in another embodiment from about 0.1% to about 1%, by weight of the personal cleansing composition, of the antibacterial agents. Examples of antimicrobial agents that can be used herein include a pyrithione or a polyvalent metal salt of pyrithione such as a zinc salt of 1-hydroxy-2-pyridinethione (known as "zinc pyrithione" or "ZPT"), carbanilides, for example, triclocarban (also known as trichlorocarbanilide), triclosan, a halogenated diphenylether available as DP-300 from Ciba-Geigy, hexachlorophene, 3,4,5-tribromosalicylanilide, and salts of 2-pyridinethiol-1-oxide, salicylic acid and other organic acids. Other suitable antimicrobial agents are described in detail in US 6,488,943 (referred to as antimicrobial actives).

    [0031] The polyacrylate microcapsules useful herein are those releasing the benefit agents for a period of time after initial application. Potential trigger mechanisms for release of the encapsulated benefit agents may include, but are not limited to, mechanical forces, dehydration, light, pH, temperature, or even changes in ionic strength.

    Process of Making Anionic Polyacrylate Microcapsules



    [0032] An anionic polyacrylate microcapsule can be formed by either: (1) coating an already formed microcapsule with an anionic emulsifier; or (2) adding the anionic emulsifier to the microcapsule during the microcapsule making process. Any known method for generating a microcapsule is useful herein. Example methods for making polyacrylate microcapsules are disclosed in U.S. Patent Application 61/328949; U.S. Patent Application 61/328954; U.S. Patent Application 61/328962; and U.S. Patent Application 61/328967.

    [0033] In one embodiment, polyacrlyate microcapsules are formed from water in oil, or oil in water emulsifications. During the polyacrylate microcapsule making process, a first composition is prepared as an oil phase. The oil phase may comprise oil; an oil soluble or dispersible primary, secondary, or tertiary amine; a multifunctional acrylate or methacrylate monomer or oligomer; an oil soluble acid; an initiator, and combinations thereof. In one embodiment, a nitrogen blanket is employed while the solution is mixed. Gradually, the temperature is increased to create a first composition reaction product. After the first composition reaction product is formed, a second composition is added to the reaction product.

    [0034] The second composition is prepared as a water phase. The water phase may comprise water; an emulsifier that may be water soluble or water dispersible polymer or copolymer; at least one water phase initiator; one or more of an alkali or alkali salt, and combinations thereof. By water phase initiator, it is meant that the initiator is soluble or dispersible in water.

    [0035] The second composition is then added to the oil solution of the first composition reaction product. This addition creates an oil-in-water emulsion. The reaction of the first composition in the presence of the second composition results in the formation of a low permeability microcapsule wall. The emulsion is further heated for a time and temperature sufficient to decompose the free radicals which are present in either one or both of the oil and water phases.

    [0036] Furthermore, the polymerization of the monomers and oligomers in the oil phase causes a precipitation of the polymerized material. The precipitation of microcapsule wall material forms at the interface of the water and oil phases.

    [0037] The anionic polyacrylate microcapsule is contained in the composition at a level by weight of from about 0.01% to about 50%, from about 0.05% to about 10%, from about 0.1% to about 8%, or from about 0.25% to 3%.

    [0038] The anionic polyacrylate microcapsules useful herein are those having a particle size of from about 1 micron to about 80 microns, from about 2 microns to about 50 microns, and from about 5 microns to about 30 microns.

    A. Coating a Microcapsule



    [0039] In one embodiment of the invention, the anionic emulsifier is added to an already formed polyacrylate microcapsule. The anionic emulsifier attaches to the surface of the microcapsule through hydrogen bonding, van der Waals forces, ionic interactions, hydrophobic interactions, or chemical reactions. In one aspect, the anionic emulsifier surrounds at least a part of the external surface of the polyacrylate microcapsule, or is physically or chemically bound to the external surface of the polyacrylate microcapsule.

    B. Adding Anionic Emulsifier to a Microcapsule



    [0040] In another embodiment, the anionic emulsifier associates with the microcapsule surface during the microcapsule making process. When making the microcapsule, the anionic emulsifier is solubilized in an aqueous phase, which may optionally contain a free radical initiator, prior to emulsification of the oil. The excess aqueous phase is then added to the oil phase to form an oil-in-water emulsion. The emulsion is then heated for a time and at a temperature sufficient to decompose the free radicals which are positioned in one or both of the oil and aqueous phases. Microcapsule wall material is thereby formed at the interface of the water and oil phases. In one embodiment, when the emulsifier is comprised of acrylate moieties, the emulsifier may become chemically bound to the interfacial wall material.

    C. Forming the Premix



    [0041] Once the anionic polyacrlyate microcapsule is formed by either formation step, the anionic polyacrylate microcapsule is added to a specific cationic deposition polymer to form a premix. It has been surprisingly found that the anionic charge on the polyacrylate microcapsule leads to the formation of a microstructure on the shell of the microcapsule when combined with a cationic deposition polymer in the premix. This premix exhibits anionic polyacrylate microcapsules that have a higher viscoelasticity to the hair and/or skin than microcapsules without an anionic charge and specific cationic deposition polymer thus giving a benefit to the situs.

    Slurry/Aggolmerate



    [0042] In one embodiment, the anionic polyacrylate microcapsules are contained in a slurry. The slurry may be combined with an adjunct ingredient to form a composition, for example, a conditioning consumer product.

    [0043] In one aspect, the slurry may comprise one or more processing aids, selected from the group consisting of water, aggregate inhibiting materials such as divalent salts; particle suspending polymers such as xanthan gum, guar gum, and carboxy methyl cellulose. In another embodiment, said processing aids may be selected from the group consisting of amphoteric surfactants such as cocamidopropyl betaine (CAPB), zwitterionic surfactants, cationic swellable polymers, latex particles such as acrylic based ester Rheovis CDE, and mixtures thereof.

    [0044] In one aspect, the slurry may comprise a carrier selected from the group consisting of polar solvents, including but not limited to, water, ethylene glycol, propylene glycol, polyethylene glycol, glycerol; nonpolar solvents, including but not limited to, mineral oil, perfume raw materials, silicone oils, hydrocarbon paraffin oils, and mixtures thereof.

    [0045] In another embodiment, the anionic polyacrylate microcapsules are contained in an agglomerate with a second material. In one aspect, said second materials may comprise a material selected from the group consisting of silicas, citric acid, sodium carbonate, sodium sulfate, sodium chloride, and binders such as sodium silicates, modified celluloses, polyethylene glycols, polyacrylates, polyacrylic acids, zeolites and mixtures thereof.

    Cationic Deposition Polymer



    [0046] The personal cleansing composition of the present invention comprises a cationic deposition polymer that forms a premix when added to the anionic polyacrylate microcapsules. Any known natural or synthetic cationic deposition polymer can be used herein. Examples include those polymers disclosed in U.S. Patent 6,649,155; U.S. Patent Application 12/103,902; U.S. Patent Publication 2008/0206355; and U.S. Patent Publication No. 2006/0099167A1.

    [0047] The cationic deposition polymer is included in the composition at a level from about 0.01% to about 2%, in one embodiment from about 1.5% to about 1.9%, in another embodiment from about 1.8% to about 2.0%, in view of providing the benefits of the present invention.

    [0048] The cationic deposition polymer is a water soluble polymer with a charge density from about 0.5 milliequivalents per gram to about 12 milliequivalents per gram. The cationic deposition polymer used in the composition has a molecular weight of about 100,000 Daltons to about 5,000,000 Daltons. The cationic deposition polymer is a low charge density cationic polymer.

    [0049] In one embodiment, the cationic deposition polymer is a synthetic cationic deposition polymer. A variety of synthetic cationic deposition polymers can be used including mono- and di-alkyl chain cationic surfactants. In one embodiment, mono-alkyl chain cationic surfactants are chosen including, for example, mono-alkyl quaternary ammonium salts and mono-alkyl amines. In another embodiment, di-alkyl chain cationic surfactants are used and include, for example, dialkyl (14-18) dimethyl ammonium chloride, ditallow alkyl dimethyl ammonium chloride, dihydrogenated tallow alkyl dimethyl ammonium chloride, distearyl dimethyl ammonium chloride, dicetyl dimethyl ammonium chloride, and mixtures thereof.

    [0050] In another embodiment, the cationic deposition polymer is a naturally derived cationic polymer. The term, "naturally derived cationic polymer" as used herein, refers to cationic deposition polymers which are obtained from natural sources. The natural sources may be polysaccharide polymers. Therefore, the naturally derived cationic polymer may be selected from the group comprising starches, guar, cellulose, Cassia, locust bean, Konjac, Tara, galactomannan, tapioca, and synthetic polymers. In a further embodiment, cationic deposition polymers are selected from Mirapol 100S (Rhodia), Jaguar C17, polyDADMAC, Tapioca starch (Akzo), polyTriquat, and mixtures thereof.

    Forming a Premix



    [0051] The cationic deposition polymer and the anionic polyacrylate microcapsule are mixed to form a premix before addition to the personal cleansing composition comprising a detersive surfactant and a carrier.

    [0052] The weight ratio of the anionic polyacrylate microcapsule to the cationic deposition polymer (based on the dry weight of the anionic microcapsules and the dry weight of the cationic deposition polymer) is from about 0.5:30 to about 20:1, from about 5:15 to about 15:1, and from about 5:1 to about 12:1. It is believed that too much cationic polymer may not provide enhanced and/or prolonged benefits to the benefit agent microcapsules due to the formation of excess cationic polymer coating on the capsule wall. This excess coating may prevent the microcapsule wall from breaking and releasing the benefit agents.

    [0053] Microcapsules and anionic emulsifiers may be dispersed in solvents such as water while mixing with the cationic deposition polymer. In one embodiment, the amount of water present is from about 90% to about 50%, in another embodiment from about 70% to about 50%, and in another embodiment from about 60% to about 50%. In one embodiment of the invention, the anionic emulsifiers associate with the microcapsule walls to form anionic polyacrylate microcapsules prior to their mixing with cationic deposition polymers.

    Detersive Composition



    [0054] The detersive composition can be all aqueous phase or may comprise both an oil phase and an aqueous phase. In one embodiment, the detersive composition has both an oil phase and an aqueous phase. After being added to the detersive composition, the polyacrylate microcapsules reside in the aqueous phase of such embodiments.

    [0055] The detersive composition may comprise any combination of the following components:

    A. Detersive Surfactant



    [0056] The personal cleansing composition of the present invention includes a detersive surfactant. The detersive surfactant provides cleaning performance to the composition. The detersive surfactant in turn comprises anionic, nonionic, cationic, zwitterionic, amphoteric surfactants, soap, or combinations thereof. Various examples and descriptions of detersive surfactants are set forth in U.S. Patent 6,649,155; U.S. Patent Application 12/103,902; and U.S. Patent Publication 2008/0206355.

    [0057] The concentration of the anionic surfactant component in the cleansing composition should be sufficient to provide the desired cleaning and lather performance, and generally ranges from about 2% to about 50%, from about 8% to about 30%, from about 10% to about 25%, or from about 12% to about 22%.

    [0058] For example, according to one embodiment, the surfactant can comprise one or more linear anionic surfactants such as ammonium lauryl sulfate, ammonium laureth sulfate, sodium lauryl sulfate, sodium laureth sulfate, potassium laureth sulfate, sodium lauryl sarcosinate, sodium lauroyl sarcosinate, lauryl sarcosine, cocoyl sarcosine, ammonium cocoyl sulfate, potassium lauryl sulfate, and combinations thereof. In one embodiment, the surfactant comprises sodium laureth(n) sulfate, hereinafter SLEnS, where n defines the average moles of ethoxylation. In another embodiment, n ranges from greater than 0 to 8, alternatively from about 1 to about 3, alternatively about 1. It is understood that a material such as SLEnS, for example, can comprise a significant amount of molecules which have no ethoxylate, 1 mole ethoxylate, 2 mole ethoxylate, 3 mole ethoxylate, and so on in a distribution which can be broad, narrow or truncated. For example, SLE1S can comprise a significant amount of molecules which have no ethoxylate, 1 mole ethoxylate, 3 mole ethoxylate, and so on in a distribution which can be broad, narrow or truncated and still comprise SLE1S where the average of the distribution is about 1.

    [0059] The surfactant can also comprises one or more branched anionic surfactants and monomethyl branched anionic surfactants such as sodium trideceth sulfate, sodium tridecyl sulfate, sodium C12-13 alkyl sulfate, and C12-13 pareth sulfate and sodium C12-13 pareth-n sulfate.

    [0060] Suitable amphoteric or zwitterionic detersive surfactants for use in the personal cleansing composition herein include those which are known for use in personal care cleansing. Concentrations of such amphoteric detersive surfactants range from about 0.5% to about 20%, and from about 1% to about 10%. Non limiting examples of suitable zwitterionic or amphoteric surfactants are described in U.S. Pat. Nos. 5,104,646 (Bolich Jr. et al.), 5,106,609 (Bolich Jr. et al.).

    [0061] Amphoteric surfactant suitable for use in the personal cleansing composition described herein include those that are broadly described as derivatives of aliphatic secondary and tertiary amines in which the aliphatic radical can be straight or branched chain and wherein one of the aliphatic substituents contains from about 8 to about 18 carbon atoms and one contains an anionic water solubilizing group, e.g., carboxy, sulfonate, sulfate, phosphate, or phosphonate. Examples of compounds falling within this definition include sodium 3-dodecyl-aminopropionate, sodium 3-dodecylaminopropane sulfonate, sodium lauryl sarcosinate, N-alkyltaurines such as the one prepared by reacting dodecylamine with sodium isethionate according to the teaching of U.S. Pat. No. 2,658,072, N-higher alkyl aspartic acids such as those produced according to the teaching of U.S. Pat. No. 2,438,091, and the products described in U.S. Pat. No. 2,528,378. In an embodiment, the surfactant included in the personal cleansing composition described herein can comprise an amphoteric surfactant that is selected from the group consisting of sodium lauroamphoacetate, sodium cocoamphoactetate, disodium lauroamphoacetate disodium cocodiamphoacetate, and mixtures thereof.

    [0062] Zwitterionic surfactants suitable for use in the surfactant of the personal cleansing composition described herein include those that are broadly described as derivatives of aliphatic quaternary ammonium, phosphonium, and sulfonium compounds, in which the aliphatic radicals can be straight or branched chain, and wherein one of the aliphatic substituents contains from about 8 to about 18 carbon atoms and one contains an anionic group, e.g., carboxy, sulfonate, sulfate, phosphate, or phosphonate. In one embodiment, the zwitterionic surfactant included in the personal cleansing composition described herein can comprise one or more betaines such as cocoamidopropyl betaine.

    B. Aqueous Carrier



    [0063] The formulations of the present invention can be in the form of pourable liquids (under ambient conditions). Such compositions will therefore typically comprise an aqueous carrier, which is present at a level of from about 20% to about 95%, or even from about 60% to about 85%. The aqueous carrier may comprise water, or a miscible mixture of water and organic solvent, and in one aspect may comprise water with minimal or no significant concentrations of organic solvent, except as otherwise incidentally incorporated into the composition as minor ingredients of other essential or optional components.

    [0064] The carrier useful in the present invention includes water and water solutions of lower alkyl alcohols and polyhydric alcohols. The lower alkyl alcohols useful herein are monohydric alcohols having 1 to 6 carbons, in one aspect, ethanol and isopropanol. The polyhydric alcohols useful herein include propylene glycol, hexylene glycol, glycerin, and propane diol.

    Method of Manufacture



    [0065] The personal cleansing compositions of the present invention can be prepared by the process comprising: 1) coating a polyacrylate microcapsule with an anionic emulsifier to form an anionic polyacrylate microcapsule; 2) combining the anionic polyacrylate microcapsule with a cationic deposition polymer to form a premix; and 3) adding the premix to a detersive composition comprising surfactant and a carrier.

    [0066] In another embodiment, the personal cleansing compositions of the present invention can be prepared by the process comprising: 1) coating a polyacrylate microcapsule with an anionic emulsifier to form an anionic polyacrylate microcapsule; 2) combining the anionic polyacrylate microcapsule with a cationic deposition polymer to form a premix; 3) adding the premix to a anionic surfactant; and 4) adding the resulting composition of step (3) to a detersive composition comprising surfactant and a carrier.

    [0067] It has been unexpectedly found that the association of anionic polyacrylate microcapsules combined with cationic deposition polymers has a higher viscoelasticity than in the absence of the mixed components thus giving a better adhesion of the anionic microcapsules to the hair.

    [0068] For example, when an anionic emulsifier comprising a copolymer of acrylic acid and butyl acrylate (molecular weight of 40,000 g/mol), is mixed with various cationic polymers to form a polymer premix, the result is a significant increase in viscoelasticity. This increase indicates a strong polyelectrolyte interaction which is exemplified in the increase in viscoelastic component G' as the quantity of cationic polymer increases (See Table 1)
    Table 1. Viscoelasticity as a function of anionic:cationic polymer premix ratio.
    Sample DescriptionAnionic Emulsifier (wt%)Cationic Polymer (wt%)Anionic Surfactant (wt%)G' at 1 Hz (Pascals)G" at 1 Hz (Pascals)
    1:5 Anionic:Cationic 5.10% 25.48% 0.00% 0.369 6.55
    1:10 Anionic:Cationic 2.78% 27.79% 0.00% 0.178 7.22
    1:20 Anionic:Cationic 1.46% 29.12% 0.00% 0.233 7.92


    [0069] Furthermore, when an anionic surfactant is added to the polymer premix, a substantial increase in viscoelasticity is also noted. Such an increase in viscoelasticity is influenced by the strength of the association between the cationic deposition polymer and the anionic surfactant. This is exemplified in the increase in viscoelastic component G' upon addition of anionic surfactant to the premix (See Table 2).
    Table 2. Viscoelasticity as a function of anionic surfactant addition to polymer premix.
    Sample IDAnionic EmulsifierCationic PolymerAnionic SurfactantG' at 1 Hz (Pascals)G" at 1 Hz (Pascals)
    1:5 Anionic:Cationic 3.05% 15.25% 10.87% 42 105.6
    1:10 Anionic:Cationic 1.65% 16.48% 11.74% 37.1 7.1
    1:20 Anionic:Cationic 0.86% 17.17% 12.23% 118.2 133.9


    [0070] In one embodiment of the invention, an anionic emulsifier is covalently bonded to the outer wall of the polyacrylate microcapsule by incorporating the anionic emulsifier during the microcapsule making process. In another embodiment, the anionic emulsifier is added to the slurry comprising a fully formed polyacrylate microcapsule. After forming the anionic polyacrylate microcapsule through either step, a cationic deposition polymer is then added to the anionic microcapsule to form a viscoelastic premix. When this premix is then combined with an anionic surfactant, an association of polymers forms a microstructure on the anionic polyacrylate microcapsule wall. The microstructure forms even upon dilution of the personal cleansing composition. Once formed, the high viscosity of the polymer association microstructure results in an anionic polyacrylate microcapsule that maintains its microcapsule structure even upon dilution of the personal cleansing composition. In addition, the microcapsule structure provides multiple points of contact to the substrate which works to increase the amount of time the microcapsule is on the situs.

    [0071] The polyacrylate microcapsules of the present invention can be formulated into any suitable form and prepared by any process chosen by the formulator, non-limiting examples of which are described in U.S. 5,879,584; U.S. 5,691,297; U.S. 5,574,005; U.S. 5,569,645; U.S. 5,565,422; U.S. 5,516,448; U.S. 5,489,392; U.S. 5,486,303.

    Product Forms



    [0072] The personal cleansing compositions of the present invention can be in the form of rinse-off products or leave-on products, and can be formulated in a wide variety of product forms, including but not limited to creams, gels, emulsions, mousses and sprays.

    [0073] In one embodiment, the personal cleansing composition is in the form of a gel comprising less than about 45% water. In such embodiment, the gel may have a neat viscosity of about 1,000 cps to about 10,000 cps. The neat viscosity of a gel can be defined as the viscosity of the fluid at a shear rate of 1/sec. Scientifically, viscosity is the ratio of shear stress to shear rate. In some embodiments, the range of shear rates for gels is from 0.01/sec to 10/sec.

    [0074] Neat viscosity of the gel product form can be measured with a rheometer according to the following method:
    1. (1) Load the sample onto the plate.
    2. (2) Establish a gap of 1 millimeter between the 1 degree cone and the plate.
    3. (3) Perform a shear sweep on the fluid from 0.01/sec to 10/sec.
    4. (4) Record the shear stress response of the fluid.
    5. (5) Determine the neat viscosity of the fluid by calculating the ratio of shear stress to shear rate at each shear rate.


    [0075] As noted herein, the personal cleansing composition may include a structured cleansing phase and a benefit phase. In one embodiment, the structured cleansing phase and the benefit phase can be in physical contact. In one embodiment, the personal cleansing composition can be a multiphase personal cleansing composition where the structured cleansing phase and the benefit phase can be blended or mixed to a significant degree, but still be physically distinct such that the physical distinctiveness is undetectable to the naked eye.

    [0076] In certain embodiments, the personal cleansing composition can be a multiphase personal cleansing composition where the structured cleansing phase and the benefit phase can be made to occupy separate but distinct physical spaces inside a package in which the phases can be stored. In such an embodiment, the structured cleansing phase and the benefit phase can be stored such that the phases are not in direct contact with one another. In another embodiment, the personal cleansing composition can be a multiphase personal cleansing composition where the structured cleansing phase and the benefit phase are in physical contact and can have a striped or marbled configuration.

    [0077] In yet another embodiment, the personal cleansing composition can include a combination of one or more of the above multiphase personal cleansing compositions. In one such embodiment, one blended multiphase personal cleansing composition can be stacked as stripes with another blended multiphase personal cleansing composition. And in another such embodiment, blended multiphase personal cleansing compositions distinguishable by color can be stacked as stripes wherein the blended multiphase personal cleansing compositions can be otherwise similar.

    TEST METHODS



    [0078] It is understood that the test methods that are disclosed in the Test Methods Section of the present application should be used to determine the respective values of the parameters of Applicants' invention as such invention is described and claimed herein.

    A. ClogP



    [0079] The "calculated logP" (ClogP) is determined by the fragment approach of Hansch and Leo (cf., A. Leo, in Comprehensive Medicinal Chemistry, Vol. 4, C. Hansch, P.G. Sammens, J.B. Taylor, and C.A. Ramsden, Eds. P. 295, Pergamon Press, 1990,). ClogP values may be calculated by using the "CLOGP" program available from Daylight Chemical Information Systems Inc. of Irvine, California U.S.A..

    B. Boiling Point



    [0080] Boiling point is measured by ASTM method D2887-04a, "Standard Test Method for Boiling Range Distribution of Petroleum Fractions by Gas Chromatography," ASTM International.

    C. Median Particle Size



    [0081] Particle size is measured using an Accusizer 780A, made by Particle Sizing Systems, Santa Barbara CA. The instrument is calibrated from 0 to 300µ using Duke particle size standards. Samples for particle size evaluation are prepared by diluting about 1g of capsule slurry in about 5g of de-ionized water and further diluting about 1g of this solution in about 25g of water.

    [0082] About 1g of the most dilute sample is added to the Accusizer and the testing initiated, using the autodilution feature. The Accusizer should be reading in excess of 9200 counts/second. If the counts are less than 9200 additional sample should be added. The accusizer will dilute the test sample until 9200 counts/second and initiate the evaluation. After 2 minutes of testing the Accusizer will display the results, including volume-weighted median size.

    [0083] The broadness index can be calculated by determining the particle size at which 95% of the cumulative particle volume is exceeded (95% size), the particle size at which 5% of the cumulative particle volume is exceeded (5% size), and the median volume-weighted particle size (50% size-50% of the particle volume both above and below this size). Broadness Index (5) = ((95% size)-(5% size)/50% size).

    D. Fracture Strength Test Method



    [0084] Analysis steps include:
    1. a.) Place 1 gram of particles in 1 liter of distilled deionized (DI) water.
    2. b.) Permit the particles to remain in the DI water for 10 minutes and then recover the particles by filtration, using a 60 mL syringe filter, 1.2 micron nitrocellulose filter (Millipore, 25mm diameter).
    3. c.) Determine the rupture force of 50 individual particles. The rupture force of a particle is determined using the procedure given in Zhang, Z.; Sun, G; "Mechanical Properties of Melamine-Formaldehyde microcapsules," J. Microencapsulation, vol 18, no. 5, pages 593-602, 2001. Then calculate the fracture strength of each particle by dividing the rupture force (in Newtons) by the cross-sectional area of the respective spherical particle (πr2, where r is the radius of the particle before compression), said cross-sectional area being determined as follows: measuring the particle size of each individual particle using the experimental apparatus and method of Zhang, Z.; Sun, G; "Mechanical Properties of Melamine-Formaldehyde microcapsules," J. Microencapsulation, vol 18, no. 5, pages 593-602, 2001.
    4. d.) Use the 50 independent measurements from c.) above, and calculate the percentage of particles having a fracture strength within the claimed range fracture strength range.

    E. Zeta Potential



    [0085] 
    1. (1) Equipment specifications: Malvern Zeatasizer Nano Model ZEN3600 Sample cell, disposable capillary cell (green cell)
    2. (2) Use Duke standards to measure the PSD, and use it to measure the zeta potential to assure that the instrument is functioning properly.
    3. (3) Flush a DTS1060 capillary cell with 1-2 mL ethanol, the with DI water to prepare the capillary cell.
    4. (4) Sample preparation: first, filter 20 mL DI water through 0.2 micron filter into a 20 mL vial. Add 1 drop (50 microliters of 30wt% solids particulat suspension into the vial and invert the sample back and forth gently until the particulate suspension is homogeneously dispersed in the vial. Next, rinse a DTS1060 green disposable zeta cell with 1-2 mL of DI water, then use a syringe to transfer the sample solution from the vial into the zeta cell, making sure that no air bubbles are present in the cell. Fill the cell to the top, then place a cap on the cell outlet and inlet (again making sure no air bubbles are present in the sample cell). Then, place the cell in the sample chamber, with the electrodes facing the sides of the system. Finally, place the sample cell in the instrument.
    5. (5) Conditions for the run:
      1. a. Refractive index = 1.35 (this number may vary for suspensions. One can measure the refractive index for any particulate suspension using a refractometer)
      2. b. Temperature = 25 degrees Centigrade
      3. c. Equilibration time = 1 minute
      4. d. Smoluchowski model to be used to calculate the zeta potential
    6. (6) Measure each sample in triplicate. The result from the instrument is reported as Zeta Potential in milliVolts, with no extrapolation.

    EXAMPLES



    [0086] A perfume composition, called Scent A, is utilized to prepare the examples of the invention. The table below lists the ingredients, and their properties. Table 2 provides the ClogP breakdown of the perfume oil composition.
    Table 1.
    Material NameClogPBoiling Point °C
    Beta Gamma Hexenol 1.3 155
    Phenyl Ethyl Alcohol 1.32 219
    Helional 1.77 329
    Triplal Extra 1.78 199
    Amyl- Acetate (isomer Blends) 1.87 135
    Melonal 2.09 182
    Liffarome 2.14 167
    Iso Eugenol Acetate 2.17 303
    Cis 3 Hexenyl Acetate 2.18 167
    Jasmolactone 2.36 219
    2' 6-nonadien-1-ol 2.43 213
    Florosa 2.46 238
    Nonalactone 2.66 193
    Cis Jasmone 2.81 254
    Ethyl Linalool 2.92 223
    Pino Acetaldehyde 2.98 261
    Methyl Dihydro Jasmonate 3.01 323
    Undecavertol 3.06 242
    Azurone 10/tec 0015573 3.06 395
    Dihydro Myrcenol 3.08 195
    Cyclemax 3.23 281
    Hivernal 3.29 351
    Pomarose 3.51 214
    Undecalactone 3.75 228
    Damascenone Total 937459 3.89 267
    Acalea (01-1963) 3.9 344
    Cis-3-hexenyl Salicylate 4 316
    Ionone Beta 4.02 267
    Polysantol 4.21 256
    Ambroxan 4.58 285
    5-cyclohexadecen-1-one 5.04 331
    Iso E Super Or Wood 5.05 325
    Laevo Muscone 5.48 321
    Helvetolide 947650 5.56 309

    EXAMPLE 1. Nonionic Microcapsule (TAS0810101, MVF1837-94B)



    [0087] An oil solution, consisting of 75g Fragrance Oil scenta, 75g of Isopropyl Myristate, 0.6g DuPont Vazo-52, and 0.4g DuPont Vazo-67, is added to a 35°C temperature controlled steel jacketed reactor, with mixing at 1000 rpm (4 tip, 2" diameter, flat mill blade) and a nitrogen blanket applied at 100cc/min. The oil solution is heated to 75°C in 45 minutes, held at 75°C for 45 minutes, and cooled to 60°C in 75 minutes.

    [0088] A second oil solution, consisting of 37.5g Fragrance Oil, 0.5g tertiarybutylaminoethyl methacrylate, 0.4g 2-carboxyethyl acrylate, and 20g Sartomer CN975 (hexafunctional urethane-acrylate oligomer) is added when the first oil solution reached 60°C. The combined oils are held at 60°C for an additional 10 minutes.

    [0089] Mixing is stopped and a water solution, consisting of 56g of 5% active polyvinyl alcohol Celvol 540 solution in water, 244g water, 1.1g 20% NaOH, and 1.2g DuPont Vazo-68WSP, is added to the bottom of the oil solution, using a funnel.

    [0090] Mixing is again started, at 2500 rpm, for 60 minutes to emulsify the oil phase into the water solution. After milling is completed, mixing is continued with a 3" propeller at 350 rpm. The batch is held at 60°C for 45 minutes, the temperature is increased to 75°C in 30 minutes, held at 75°C for 4 hours, heated to 90°C in 30 minutes and held at 90°C for 8 hours. The batch is then allowed to cool to room temperature. The finished microcapsules have a median particle size of 6.4 microns, a broadness index of 1.3, and a zeta potential of negative 0.5 millivolts, and a total scent A concentration of 27.6wt%.

    EXAMPLE 2. Anionic Microcapsule, large particle size (TAS1122101)



    [0091] Capsules are made using identical materials, compositions, and process conditions as in Example 1 with the following exceptions: 1 gram of Vazo-52, 0.8 grams of Vazo-67, 0.3 grams of tertiarybutylaminoethyl methacrylate, 0.25 grams of 2-carboxyethyl acrylate, and 12 grams of Sartomer CN975 as compositional differences in the oil phase; and 22 grams of 25% active Colloid 351, and 308 grams of water as compositional differences in the water phase. All other mixing and process conditioner remains the same. The finished microcapsules have a median particle size of 10.7 microns, a broadness index of 1.5, and a zeta potential of negative 60 milivolts, and a total scent A concentration of 34.9wt%.

    EXAMPLE 3. Anionic Microcapsule, small particle size (TAS1123101)



    [0092] Capsules are made using identical materials, compositions, and process conditions as in Example 1 with the following exceptions: 1 gram of Vazo-52, 0.8 grams of Vazo-67, 1.5 grams of tertiarybutylaminoethyl methacrylate, 1.2 grams of 2-carboxyethyl acrylate, and 60 grams of Sartomer CN975 as compositional differences in the oil phase; and 68 grams of 25% active Colloid 351, and 282 grams of water as compositional differences in the water phase. All other mixing and process conditioner remains the same. The finished microcapsules have a median particle size of 1.4 microns, a broadness index of 1.2, and a zeta potential of negative 60 milivolts, and a total scent A concentration of 20.7wt%.

    EXAMPLE 4. Anionic Microcapsule (TAS1101101)



    [0093] Capsules are made using identical materials, compositions, and process conditions as in Example 2 with the following exceptions: 1 gram of tertiarybutylaminoethyl methacrylate, 0.8 grams of 2-carboxyethyl acrylate, and 40 grams of Sartomer CN975 as compositional differnces in the oil phase; and 22 grams of 25% active Colloid 351, and 282 grams of water as compositional differences in the water phase. All other mixing and process conditioners remain the same.

    [0094] The finished microcapsules have a median particle size of 4.8 microns, a broadness index of 1.3, and a zeta potential of negative 60 milivolts, and a total scent A concentration of 23.5wt%.

    EXAMPLE 5. Body Cleansing Composition



    [0095] The microcapsules of Example 1, 2, and 4 are formulated into a body cleansing composition. The anionic microcapsules of example 2 and 4 are first mixed with a 15wt% solution of tapioca starch (Akzo) to form a viscoelastic mixture:
    Microcapsules of ExampleMicrocapsule (g)15% Tapioca Starch Solution (g)Water (g)Final Perfume Content wt%
    2 (Premix 2) 4.1 2.38 3.52 14.31%
    4 (Premix 4) 6.09 2.38 1.53 14.31%


    [0096] This premix is then added to the body cleansing composition below, mixed at 1900 RPM for 1 minute using a DAFC 400FVZ speed mixer.
     Example 5AExample 5BExample 5CExample 5D
    I: Cleansing Phase Composition        
    Sodium Trideceth Sulfate (sulfated from Iconol TDA-3 (BASF Corp.) to >95% sulfate) 5.9 5.9 5.9 5.9
    Sodium Lauryl Sulfate (Procter and Gamble) 5.9 5.9 5.9 5.9
    Sodium Lauroamphoacetate (Cognis Chemical Corp.,) 3.6 3.6 3.6 3.6
    Guar Hydroxypropyltrimonium Chloride (N-Hance 3196 from Aqualon) 0.3 0.3 0.7 0.7
    Stabylen 30 (Acrylates/Vinyl Isodecanoate, 3V) 0.33 0.33 0.33 0.33
    Sodium Chloride 3.75 3.75 3.75 3.75
    Trideceth-3 (Iconal TDA-3 from BASF Corp.) 1.75 1.75 1.75 1.75
    Methyl chloro isothiazolinone and methyl isothiazolinone (Kathon CG, Rohm & Haas) 0.033 0.033 0.033 0.033
    EDTA (Dissolvine NA 2x) 0.15 0.15 0.15 0.15
    Sodium Benzoate 0.2 0.2 0.2 0.2
    Citric Acid, titrate pH = 5.7 ± 0.2 pH = 5.7 ± 0.2 pH = 5.7 ± 0.2 pH = 5.7 ± 0.2
    Scent A 0.4 0.0 0.0 0.0
    Perfume Microcapsule Example None 1 Premix 2 Premix 4
    Polyacrylate Microcapsule Premix (0.4% perfume usage level) 0 1.45 1.40 1.40
    Water and Minors (NaOH) Q.S. Q.S. Q.S. Q.S.
    II: Benefit Phase Composition        
    Petrolatum (G2218 from Sonnerbonn) 70 70 70 70
    Mineral Oil (Hydrobrite 1000 from Sonnerbonn) 30 30 30 30
    III: Surfactant Phase : Benefit Phase Ratio Blending 50:50 50:50 50:50 50:50
             


    [0097] Each product above is tested for olfactive performance on a forearm, using the following protocol:
    • Saturate puff under running water for 5 seconds. (95 deg. F +/- 5 deg. F; ∼1.8L/min)
    • Wet forearm under running water for 5 seconds, elbow to wrist.
    • Dispense 1 mL product(s) into opposite palm.
    • Rub product on application arm for 5 seconds. Rub palm along the edge of arm to remove excess from palm.
    • Do NOT rewet puff. LIGHTLY wash the inner forearm for 10 seconds in long, circular strokes. It should foam, if it's streaking, lighten pressure.
    • Allow 15 second residence time.
    • Rinse forearm with running water for 15 seconds.
    • Dry with clean paper towels by laying paper towel on lower arm and walking opposite hand along full, inner arm (elbow to wrist), no rubbing.
    • Perform no measurements for at least 30 seconds, leaving arm open to air during this time.
    • Evaluate the olfactive performance of the arm before rubbing and after rubbing, for different periods of aging the arm (and exposing to ambient air).

    INTENSITY SCALE 1-100 (No odor - most intense possible)



    [0098] 
    ExampleDuring Use/LatherInitial Dry Pre-rub / Post-rub4 hr Pre-rub / Post-rub6 hr Pre-rub / Post-rub8 hr Pre-rub / Post-rub
    5A comparative 75 70 / 70 50 / 50 40 / 40 30 / 30
    5B 75 70 / 70 50 / 50 40 / 40 30 / 30
    5C 70 65 / 70 50 / 65 40/50 30/40
    5D 70 65 / 65+ 50 / 60+ 40/50 30/40


    [0099] Notice the much higher intensity of fragrance is detected at each fragrance longevity time point (vs. control 5A) when premixes of anionic microcapsule and cationic polymer are added to the body cleansing composition.


    Claims

    1. A personal cleansing composition comprising:

    (a) a premix, the premix comprising from 0.001% to 10%, by weight of the personal cleansing composition, of an anionic charged polyacrylate microcapsule and from 0.01% to 2%, by weight of the personal cleansing composition, of a cationic deposition polymer;

    (b) from 2% to 50%, by weight of the personal cleansing composition, of a detersive surfactant; and

    (c) a carrier.


     
    2. The personal cleansing composition of Claim 1, wherein the anionic charged polyacrylate microcapsule comprises an anionic emulsifier and a polyacrylate microcapsule.
     
    3. The personal cleansing composition of Claim 2, wherein the anionic emulsifier surrounds at least a part of the external surface of the polyacrylate microcapsule, or is physically or chemically bound to the external surface of the polyacrylate microcapsule.
     
    4. The personal cleansing composition of any of Claims 2 or 3, wherein the anionic emulsifier and the polyacrylate microcapsule are mixed such that the weight ratio of the anionic emulsifier to the polyacrylate microcapsule is from 1.0 : 40 to 0.5 : 5.
     
    5. The personal cleansing composition of any of the preceding claims, wherein the anionic charged polyacrylate microcapsule and the cationic deposition polymer are mixed such that the weight ratio of the anionic charged polyacrylate microcapsule to the cationic deposition polymer is from 1.0 : 0.01 to 1.0 : 10.
     
    6. The personal cleansing composition of any of the preceding claims, wherein the anionic emulsifier is selected from the group consisting of: Poly(meth)acrylic acid; copolymers of (meth)acrylic acids and its (meth)acrylates with C1-C22 alkyl; copolymers of (meth)acrylic acids and (meth)acrylamide; and mixtures thereof.
     
    7. The personal cleansing composition of any of the preceding claims, wherein the anionic polyacrylate microcapsule has a particle size of from 2 microns to 80 microns.
     
    8. The personal cleansing composition of any of the preceding claims, wherein the polyacrylate microcapsule has a core and a shell that encapsulates said core.
     
    9. The personal cleansing composition of any of the preceding claims, wherein the core comprises from 6% to 99.9% of a benefit agent.
     
    10. The personal cleansing composition of any of the preceding claims, wherein the cationic deposition polymer is a water-soluble polymer with a charge density of from 0.5 milliequivalents per gram to 12 milliequivalents per gram, and wherein the cationic deposition polymer has a molecular weight of 100,000 Daltons to 5,000,000 Daltons.
     
    11. The personal cleansing composition of any of the preceding claims, wherein the detersive surfactant is anionic, nonionic, cationic, zwitterionic, amphoteric, soap, or combinations thereof.
     
    12. The personal cleansing composition of any of the preceding claims, wherein the anionic charged polyacrylate microcapsule is contained in an agglomerate, and wherein the agglomerate comprises materials selected from the group consisting of silicas, citric acid, sodium carbonate, sodium sulfate, sodium chloride, and binders such as sodium silicates, modified celluloses, polyethylene glycols, polyacrylates, polyacrylic acids, zeolites and mixtures thereof.
     
    13. The personal cleansing composition of any of the preceding claims, wherein the personal cleansing composition is in the form of a gel, and wherein the gel comprises less than 45% water.
     
    14. The personal cleansing composition of Claim 13, wherein the gel has a neat viscosity of 1,000 cps to 10,000 cps.
     
    15. A method of making a personal cleansing composition, said method comprising the steps of:

    a) coating a polyacrylate microcapsule with an anionic emulsifier to form an anionic polyacrylate microcapsule;

    b) combining the anionic polyacrylate microcapsule with a cationic deposition polymer to form a premix;

    c) adding the premix to a detersive composition comprising surfactant and a carrier.


     


    Ansprüche

    1. Körperreinigungszusammensetzung, umfassend:

    (a) eine Vormischung, wobei die Vormischung zu 0,001 % bis 10 %, bezogen auf das Gewicht der Körperreinigungszusammensetzung, eine anionisch geladene Polyacrylat-Mikrokapsel und zu 0,01 % bis 2 %, bezogen auf das Gewicht der Körperreinigungszusammensetzung, ein kationisches Abscheidepolymer umfasst;

    (b) zu 2 % bis 50 %, bezogen auf das Gewicht der Körperreinigungszusammensetzung, ein reinigungsaktives Tensid; und

    (c) einen Träger.


     
    2. Körperreinigungszusammensetzung nach Anspruch 1, wobei die anionisch geladene Polyacrylat-Mikrokapsel ein anionisches Emulgiermittel und eine Polyacrylat-Mikrokapsel umfasst.
     
    3. Körperreinigungszusammensetzung nach Anspruch 2, wobei das anionische Emulgiermittel zumindest einen Teil der äußeren Oberfläche der Polyacrylat-Mikrokapsel umgibt oder physikalisch oder chemisch an die äußere Oberfläche der Polyacrylat-Mikrokapsel gebunden ist.
     
    4. Körperreinigungszusammensetzung nach einem der Ansprüche 2 oder 3, wobei das anionische Emulgiermittel und die Polyacrylat-Mikrokapsel in einer Weise vermischt sind, dass das Gewichtsverhältnis des anionischen Emulgiermittels zur Polyacrylat-Mikrokapsel von 1,0:40 bis 0,5:5 beträgt.
     
    5. Körperreinigungszusammensetzung nach einem der vorangehenden Ansprüche, wobei die anionisch geladene Polyacrylat-Mikrokapsel und das kationische Abscheidepolymer in einer Weise vermischt sind, dass das Gewichtsverhältnis der anionisch geladenen Polyacrylat-Mikrokapsel zum kationischen Abscheidepolymer vom 1,0:0,01 bis 1,0:10 beträgt.
     
    6. Körperreinigungszusammensetzung nach einem der vorangehenden Ansprüche, wobei das anionische Emulgiermittel ausgewählt ist aus der Gruppe, bestehend aus: Poly(meth)acrylsäure; Copolymeren von (Meth)Acrylsäuren und deren (Meth)Acrylaten mit C1- bis C22-Alkyl; Copolymeren von (Meth)Acrylsäuren und (Meth)Acrylamid; und Mischungen davon.
     
    7. Körperreinigungszusammensetzung nach einem der vorangehenden Ansprüche, wobei die anionische Polyacrylat-Mikrokapsel eine Partikelgröße von 2 Mikrometern bis 80 Mikrometern aufweist.
     
    8. Körperreinigungszusammensetzung nach einem der vorangehenden Ansprüche, wobei die Polyacrylat-Mikrokapsel einen Kern und eine Hülle aufweist, die den Kern umhüllt.
     
    9. Körperreinigungszusammensetzung nach einem der vorangehenden Ansprüche, wobei der Kern von 6 % bis 99,9 % eines Wirkstoffs umfasst.
     
    10. Körperreinigungszusammensetzung nach einem der vorangehenden Ansprüche, wobei das kationische Abscheidepolymer ein wasserlösliches Polymer mit einer Ladungsdichte von 0,5 Milliäquivalenten pro Gramm bis 12 Milliäquivalenten pro Gramm ist und wobei das kationische Abscheidepolymer ein Molekulargewicht von 100.000 Dalton bis 5.000.000 Dalton aufweist.
     
    11. Körperreinigungszusammensetzung nach einem der vorangehenden Ansprüche, wobei das reinigungsaktive Tensid anionisch, nichtionisch, kationisch, zwitterionisch, amphoter, Seife, oder Kombinationen davon ist.
     
    12. Körperreinigungszusammensetzung nach einem der vorangehenden Ansprüche, wobei die anionisch geladene Polyacrylat-Mikrokapsel in einem Agglomerat enthalten ist und wobei das Agglomerat Materialien umfasst, die ausgewählt sind aus der Gruppe bestehend aus Kieselerden, Zitronensäure, Natriumkarbonat, Natriumsulfat, Natriumchlorid und Bindemitteln wie z. B.
    Natriumsilikaten, modifizierten Cellulosen, Polyethylenglykolen, Polyacrylaten, Polyacrylsäuren, Zeolithen und Mischungen davon.
     
    13. Körperreinigungszusammensetzung nach einem der vorangehenden Ansprüche, wobei die Körperreinigungszusammensetzung gelförmig ist und wobei das Gel weniger als 45 % Wasser umfasst.
     
    14. Körperreinigungszusammensetzung nach Anspruch 13, wobei das Gel eine unverdünnte Viskosität von 1.000 cps bis 10.000 cps aufweist.
     
    15. Verfahren zur Herstellung einer Körperreinigungszusammensetzung, wobei das Verfahren die Schritte umfasst:

    a) Beschichten einer Polyacrylat-Mikrokapsel mit einem anionischen Emulgator, um eine anionische Polyacrylat-Mikrokapsel zu bilden;

    b) Kombinieren der anionischen Polyacrylat-Mikrokapsel mit einem kationischen Abscheidepolymer, um eine Vormischung zu bilden;

    c) Hinzufügen der Vormischung zu einer reinigenden Zusammensetzung, die ein Tensid und einen Träger umfasst.


     


    Revendications

    1. Composition d'hygiène corporelle comprenant :

    (a) un prémélange, le prémélange comprenant de 0,001 % à 10 %, en poids de la composition d'hygiène corporelle, d'une microgélule de polyacrylate à charge anionique et de 0,01 % à 2 %, en poids de la composition d'hygiène corporelle, d'un polymère de dépôt cationique ;

    (b) de 2 % à 50 %, en poids de la composition d'hygiène corporelle, d'un agent tensioactif détersif ; et

    (c) un véhicule.


     
    2. Composition d'hygiène corporelle selon la revendication 1, dans laquelle la microgélule de polyacrylate à charge anionique comprend un émulsifiant anionique et une microgélule de polyacrylate.
     
    3. Composition d'hygiène corporelle selon la revendication 2, dans laquelle l'émulsifiant anionique entoure au moins une partie de la surface externe de la microgélule de polyacrylate, ou est physiquement ou chimiquement lié à la surface externe de la microgélule de polyacrylate.
     
    4. Composition d'hygiène corporelle selon l'une quelconque des revendications 2 ou 3, dans laquelle l'émulsifiant anionique et la microgélule de polyacrylate sont mélangés de telle sorte que le rapport pondéral de l'émulsifiant anionique à la microgélule de polyacrylate va de 1,0: 40 à 0,5 : 5.
     
    5. Composition d'hygiène corporelle selon l'une quelconque des revendications précédentes, dans laquelle la microgélule de polyacrylate à charge anionique et le polymère de dépôt cationique sont mélangés de telle sorte que le rapport pondéral de la microgélule de polyacrylate à charge anionique au polymère de dépôt cationique va de 1,0: 0,01 à 1,0: 10.
     
    6. Composition d'hygiène corporelle selon l'une des revendications précédentes, dans laquelle l'émulsifiant anionique est choisi dans le groupe constitué de : acide poly(méth)acrylique ; copolymères d'acides (méth)acryliques et ses (méth)acrylates avec alkyle en C1 à C22 ; copolymères d'acides (méth)acryliques et de (méth)acrylamide ; et leurs mélanges.
     
    7. Composition d'hygiène corporelle selon l'une quelconque des revendications précédentes, dans laquelle la microgélule de polyacrylate anionique a une taille des particules allant de 2 micromètres à 80 micromètres.
     
    8. Composition d'hygiène corporelle selon l'une des revendications précédentes, dans laquelle la microgélule de polyacrylate a un noyau et une enveloppe qui encapsule ledit noyau.
     
    9. Composition d'hygiène corporelle selon l'une quelconque des revendications précédentes, dans laquelle le noyau comprend de 6 % à 99,9 % d'un agent bénéfique.
     
    10. Composition d'hygiène corporelle selon l'une quelconque des revendications précédentes, dans laquelle le polymère de dépôt cationique est un polymère hydrosoluble avec une densité de charge allant de 0,5 milliéquivalent par gramme à 12 milliéquivalents par gramme, et dans laquelle le polymère de dépôt cationique a une masse moléculaire de 100 000 Daltons à 5 000 000 Daltons.
     
    11. Composition d'hygiène corporelle selon l'une des revendications précédentes, dans laquelle l'agent tensioactif détersif est anionique, non ionique, cationique, zwittérionique, amphotère, savon, ou des combinaisons de ceux-ci.
     
    12. Composition d'hygiène corporelle selon l'une des revendications précédentes, dans laquelle la microgélule de polyacrylate à charge anionique est contenue dans un agglomérat, et dans laquelle l'agglomérat comprend des matériaux choisis dans le groupe constitué de silices, acide citrique, carbonate de sodium, sulfate de sodium, chlorure de sodium, et des liants tels que silicates de sodium, celluloses modifiées, polyéthylène glycols, polyacrylates, acides polyacryliques, zéolites et leurs mélanges.
     
    13. Composition d'hygiène corporelle selon l'une quelconque des revendications précédentes, dans laquelle la composition d'hygiène corporelle est sous la forme d'un gel, et dans laquelle le gel comprend moins de 45 % d'eau.
     
    14. Composition d'hygiène corporelle selon la revendication 13, dans laquelle le gel a une viscosité pure de 1000 cP à 10 000 cP.
     
    15. Procédé de fabrication d'une composition d'hygiène corporelle, ledit procédé comprenant les étapes consistant à :

    a) revêtir une microgélule de polyacrylate avec un émulsifiant anionique de façon à former une microgélule de polyacrylate anionique ;

    b) combiner la microgélule de polyacrylate anionique avec un polymère de dépôt cationique de façon à former un prémélange ;

    c) ajouter le prémélange à une composition détersive comprenant un agent tensioactif et un véhicule.


     






    Cited references

    REFERENCES CITED IN THE DESCRIPTION



    This list of references cited by the applicant is for the reader's convenience only. It does not form part of the European patent document. Even though great care has been taken in compiling the references, errors or omissions cannot be excluded and the EPO disclaims all liability in this regard.

    Patent documents cited in the description




    Non-patent literature cited in the description